Patent US4606907A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4606907A Expired / Lapsed US ⏱️ 0.0 years remaining

Bone seeking Tc-99m complexes of phosphonate derivatives of polyamidoamines

Assignee: Dow Chemical Co
•
Filing: 1984-07-02
•
Granted: 1986-08-19
•
Expires: 2004-07-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New stable complexing agents for radionuclides which are phosphonate derivatives of certain polyamidoamines have been found which are useful in imaging the skeletal system in animals. Even though the complexing agents have high molecular weights the complexes clear rapidly and very efficiently through the kidneys, with large amounts being taken up in the bone. The ratio of uptake in bone to that in surrounding soft tissue is high even at relatively short times after injection.

Inventors

  • 👤 Jaime Simon
  • 👤 Wynn A. Volkert
  • 👤 David A. Wilson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 09:14
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/0489; A61K51/0474; A61K51/0478; A61K2123/00; Y; Y10; Y10S; Y10S424/00; Y10S424/16

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 74 words
A bone seeking complex of a radioactive nuclide and a polymer having the structural formula ##STR2## and wherein the acid groups can be in the form of alkali, alkaline earth or ammonium salts, R and R' are saturated hydrocarbon residues having from 1 to 6 and 1 to 4 carbon atoms, respectively, and m and n are 0 to 10 and wherein at least about 2/3 of Z's are R'PO 3 H 2 .
Claim 2
Dependent Claim 74 words
A bone seeking complex of a radioactive nuclide and a polymer having the structural formula ##STR2## and wherein the acid groups can be in the form of alkali, alkaline earth or ammonium salts, R and R' are saturated hydrocarbon residues having from 1 to 6 and 1 to 4 carbon atoms, respectively, and m and n are 0 to 10 and wherein at least about 2/3 of Z's are R'PO 3 H 2 .
Claim 3
Dependent Claim 17 words
The complex of claim 1 wherein R' is a --CH 2 -- group in the polymer structure.
Claim 4
Dependent Claim 19 words
The complex of claim 2 wherein each of the substituents is a methylenephosphonic acid radical or a salt thereof.
Claim 5
Dependent Claim 22 words
The complex of claim 1 wherein R is a 2-carbon residue, n is 1 and m is 1 in the polymer structure.
Claim 6
Dependent Claim 21 words
The complex of claim 4 wherein R' of the phosphorus-containing group in the polymer structure is a --CH 2 -- group.
Claim 7
Dependent Claim 11 words
The complex of claim 3 wherein the radioactive nuclide is Technetium-99m.
Claim 8
Dependent Claim 11 words
The complex of claim 2 wherein the radioactive nuclide is Technetium-99m.
Claim 9
Dependent Claim 11 words
The complex of claim 4 wherein the radioactive nuclide is Technetium-99m.
Claim 10
Dependent Claim 11 words
The complex of claim 5 wherein the radioactive nuclide is Technetium-99m.
Claim 11
Dependent Claim 16 words
A composition comprising the complex of claim 12 and a reducing agent in a saline solution.
Claim 12
Dependent Claim 16 words
A composition comprising the complex of claim 13 and a reducing agent in a saline solution.
Claim 13
Dependent Claim 16 words
A composition comprising the complex of claim 16 and a reducing agent in a saline solution.
Claim 14
Dependent Claim 16 words
A composition comprising the complex of claim 9 and a reducing agent in a saline solution.
Claim 15
Dependent Claim 13 words
The composition of claim 10 wherein the reducing agent is Sn 2+ .
Claim 16
Dependent Claim 13 words
The composition of claim 11 wherein the reducing agent is Sn 2+ .
Claim 17
Dependent Claim 13 words
The composition of claim 12 wherein the reducing agent is Sn 2+ .
Claim 18
Dependent Claim 13 words
The composition of claim 13 wherein the reducing agent is Sn 2+ .
Claim 19
Dependent Claim 90 words
In a process in which the skeletal system is imaged with a complex of a radioactive nuclide the improvement which comprises employing as the complexing agent a compound having the formula ##STR3## and wherein the acid groups can be in the form of alkali, alkaline earth or ammonium salts, R and R' are saturated hydrocarbon residues having from 1 to 6 and 1 to 4 carbon atoms, respectively, and m and n are 0 to 10 and wherein at least about 2/3 of Z's are R'PO 3 H 2 .
Claim 20
Dependent Claim 90 words
In a process in which the skeletal system is imaged with a complex of a radioactive nuclide the improvement which comprises employing as the complexing agent a compound having the formula ##STR3## and wherein the acid groups can be in the form of alkali, alkaline earth or ammonium salts, R and R' are saturated hydrocarbon residues having from 1 to 6 and 1 to 4 carbon atoms, respectively, and m and n are 0 to 10 and wherein at least about 2/3 of Z's are R'PO 3 H 2 .
Claim 21
Dependent Claim 19 words
The process of claim 18 wherein each of the substituents is a methylenephosphonic acid radical or a salt thereof.

References Cited (Backward Citations)

US3989730A Cited
US3851044A Cited
US3852414A Cited
US4016249A Cited
US4082840A Cited
US3983227A Cited
US3931396A Cited
US4032625A Cited
US4075314A Cited
US4515766A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-08-18 1990-02-17 1990-08-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-08-18 1994-02-17 1994-08-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-08-18 1998-02-17 1998-08-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag